Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic
Amy Killelea, Jeremiah Johnson, Derek T. Dangerfield, Chris Beyrer, Matthew McGough, John A. McIntyre, Rebekah E. Gee, Jeromie Ballreich, Rena M. Conti, Tim Horn, Jim Pickett, Joshua M. Sharfstein
Abstract
The U.S. has the tools to end the HIV epidemic, but progress has stagnated. A major gap in U.S. efforts to address HIV is the under-utilization of medications that can virtually eliminate acquisition of the virus, known as pre-exposure prophylaxis (PrEP). This document proposes a financing and delivery system to unlock broad access to PrEP for those most vulnerable to HIV acquisition and bring an end to the HIV epidemic.
Topics & Concepts
Human immunodeficiency virus (HIV)Pre-exposure prophylaxisMedicineVirologyBusinessMen who have sex with menSyphilisHIV/AIDS Research and InterventionsHIV, Drug Use, Sexual RiskSex work and related issues